Mark your calendars for Wednesday 6th November 2024, as Revolution Medicines (NASDAQ: RVMD) is set to unveil its third quarter financial results. This highly anticipated announcement will be made after market close, giving investors and market participants a chance to assess the company's financial performance.
According to the predictions of financial experts on Wall Street, the business is expected to announce an anticipated $0.89 loss per share for the quarter. Further, the firm is poised to disclose a total revenue of $0.75 million for the period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $1.4 million. Additionally, they forecast the earnings per share to hit loss of $3.38 for the fiscal year.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $0.99.
RVMD will host a conference call with investment community on 6th November 2024 at 04:30 PM eastern time to discuss the financial results.
Revolution Medicines (RVMD) closed Friday's regular trading session at $55.09, showing a 2.97 percent advance. During the day, RVMD shares traded between $53.43 and $55.20, with a day volume of 1.38 million shares.
